Pinheiro, Inês
Calo, Nicolas
Paolini-Bertrand, Marianne
Hartley, Oliver
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_184828)
Article History
Received: 2 November 2023
Accepted: 28 December 2023
First Online: 2 January 2024
Change Date: 28 March 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-024-57806-4
Competing interests
: Oliver Hartley is the inventor of the chemokine analogs 5P12-CCL5 and PSC-CCL5 described in this study and a shareholder of Orion Biotechnology, to whom the rights to 5P12-RANTES have been assigned.